Phibro Animal Health appoints Alejandro Bernal to board, declares $0.12 quarterly dividend

PHIBRO ANIMAL HEALTH CORP

Appointed Alejandro Bernal as independent Class III director, effective February 6, 2023.
Bernal is CEO of PetDx and former President of Mars Veterinary Health International and Global Diagnostics.
Board size increases to 9, with 6 independent directors.
Declared quarterly cash dividend of $0.12 per share, payable March 22, 2023 to holders of record March 1, 2023.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alejandro Bernal

Class III director

PAHC · PHIBRO ANIMAL HEALTH CORP

Effective: 2023-02-06
Filed: February 6, 2023, 6:59 PM ET

appointed Alejandro Bernal as a Class III director of the Corporation, effective February 6, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alejandro Bernal was appointed as Class III director at PHIBRO ANIMAL HEALTH CORP.

Action: appointed
Role: Class III director

Exact text from the filing

appointed Alejandro Bernal as a Class III director of the Corporation, effective February 6, 2023.

View on SEC.gov

PHIBRO ANIMAL HEALTH CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-011197

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.